Navigation On Topic Complete Directory About Us Add-site Link to Us

500 Health - Cancer Resources 3-D glasses may improve mammogram images Method could be a better cancer check for women with dense breast tissue. Open Open Tab June 30, 2008 Provides Information A A New Way To Look At Lung Cancer And Tobacco Carcinogens Two types of cancer-causing agents in cigarettes--a nicotine-derived chemical and polycyclic aromatic hydrocarbons (PAHs) are the main culprits in lung cancer. Exposure to tobacco smoke -- both mainstream and second-hand -- is a leading cause of cancer death in the United States. Open Open Tab May 31, 2008 Provides Information A paradigm shift for targeted cancer therapy We already know that recycling benefits our planet; and now new research suggests that the cellular version might be useful for battling cancer. Open Open Tab July 8, 2008 Provides Information A search for the best prostate cancer treatment A new Cancer Research UK clinical trial has been launched to investigate the best treatment options for men who have had surgery for early stage prostate cancer. Open Open Tab July 18, 2008 Provides Information A stem cell type supposed to be crucial for angiogenesis and cancer growth does not exist? It is widely believed that tumor angiogenesis and cancer growth critically depend on circulating endothelial precursor cells, mobilized from the bone marrow. The recent study from researchers at the University of Helsinki, Finland, and Stanford University, US, now suggests that a stem cell type supposed to be crucial for blood vessel formation and cancer growth does not actually exist. Open Open Tab April 22, 2008 Provides Information ABC, CBS, NBC Networks to Air Simulcast Cancer Fundraiser September 5 The "Stand Up to Cancer" broadcast will feature musical performances and celebrity appeals, although no guests were immediately announced Tuesday. The American Association for Cancer Research will distribute the money raised to specific organizations. Open Open Tab May 27, 2008 Provides Information Abnormalities In Gene For Melanoma Found Researchers have discovered that there are several different kinds of DNA abnormalities that can occur in a gene called the KIT gene. Open Open Tab May 30, 2008 Provides Information Accidental fungus leads to promising cancer drug A drug developed using nanotechnology and a fungus that contaminated a lab experiment may be broadly effective against a range of cancers, U.S. researchers reported on Sunday. Open Open Tab June 29, 2008 Provides Information Acupuncture reduces pain and dysfunction in head and neck cancer patients after neck dissection New data from a randomized, controlled trial found that acupuncture provided significant reductions in pain, dysfunction, and dry mouth in head and neck cancer patients after neck dissection. Open Open Tab June 1, 2008 Provides Information Acupuncture Relieves Hot Flushes In Breast Cancer Patients Taking Tamoxifen Acupuncture provides effective relief from hot flushes in women who are being treated with the anti-oestrogen tamoxifen following surgery for breast cancer, according to new research presented April 18 at the 6th European Breast Cancer Conference (EBCC-6) in Berlin. Open Open Tab April 28, 2008 Provides Information Adding Ultrasound Screening To Mammography Brings Benefits, Risks Adding a screening ultrasound examination to routine mammography reveals more breast cancers than mammography alone, according to results of a major new clinical trial. Open Open Tab May 15, 2008 Provides Information Advanced cancer patients often unaware of life expectancies, effects of chemotherapy, according to perspective Harrington said that more than 20% of Medicare beneficiaries with advanced cancer begin new chemotherapy regimens two weeks before they die, although the treatments will not benefit them. Only 37% of physicians inform patients with advanced cancer of their life expectancies, and only 31% of such patients discuss death with their physicians, according to the perspective. Open Open Tab June 11, 2008 Provides Information Advaxis Hopes to Make it Big with Listerial Cancer Vaccines A press release from Advaxis, Inc., a North Brunswick, New Jersey company, says that the firm has filed an investigational new drug application with the FDA "to assess the safety, efficacy, and immunogenicity of vaccination with Listeria monocytogenes expressing human papilloma virus Type 16 E7 (Lovaxin C) for the treatment cervical intraepithelial carcinoma stage 2/3." Open Open Tab May 27, 2008 Provides Information After cancer diagnosis, what comes next? One minute, Dr. Bernadine Healy was a perfectly healthy woman, in bed with her husband watching the Oscar De La Hoya fight on HBO. A few hours later, she was diagnosed with a malignant brain tumor. Open Open Tab May 22, 2008 Provides Information Aida Pharmaceuticals announces development of new anti-cancer drug Vasostatin-Apo2L, a pre-clinical product being developed by Aida's Shanghai Qiaer subsidiary, is a recombinant fusion protein that integrates the function of extracted fragments of Vasostatin, an inhibitor of angiogenesis and tumor growth, with the function of Rh-Apo2L, which induces the apoptosis of cancer cells Open Open Tab April 18, 2008 Provides Information Alcohol Consumption Increases Risk of Breast Cancer One of the largest studies of its kind has found that women who drink alcohol are increasing their risk for breast cancer, according to researchers at the University of Chicago. Open Open Tab April 14, 2008 Provides Information Alpha1-antitrypsin deficiency associated with increased risk of lung cancer The disorder, alpha1-antitrypsin deficiency (á1ATD), is one of the most common genetic conditions affecting the U.S. population and especially those of European descent, according to background information in the article. Individuals with two copies of the associated genetic mutation often develop emphysema at an early age. Open Open Tab May 26, 2008 Provides Information An Unexpected Way To Cause Leukemia Leukaemia -- cancer of blood or bone marrow -- is caused by mutations that allow defective blood cells to accumulate and displace healthy blood. To devise effective therapies it is crucial to know which mutations cause leukaemia and which cell type gives rise to leukaemic cells. Open Open Tab April 10, 2008 Provides Information Angiogenesis Inhibitor Formulated Through Nanotechnology Shows Promising Anticancer Results The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children's Hospital Boston. Findings were published online on June 29 by the journal Nature Biotechnology. Open Open Tab July 2, 2008 Provides Information Another HER2 Test Receives FDA Approval The FDA has given Invitrogen pre-market approval for company's new test for the HER2 gene, commonly expressed in breast cancer patients. Open Open Tab July 16, 2008 Provides Information Anti-cancer Medicines Obtained From The Elecampe, A Wild Plant Growing In The Mediterranean A group of scientists from the Department of Organic Chemistry and the Biotechnology Institute of the University of Granada have found out that the plant “Dittirichia viscose”, known as elecampe, can be used to obtain inhibitors of neurogenic vasodilatation, a significant progress in migraine and cancer treatments. Open Open Tab April 19, 2008 Provides Information Anti-estrogen drug therapy reduces risk of invasive breast cancer in older women New analysis of a drug approved for osteoporosis prevention and treatment has provided definitive evidence that the medication is also effective as a breast cancer preventative for certain cancers. Open Open Tab June 11, 2008 Provides Information Anti-estrogen Drug Therapy Reduces Risk Of Invasive Breast Cancer In Older Women New analysis of a drug approved for osteoporosis prevention and treatment has provided definitive evidence that the medication is also effective as a breast cancer preventative for certain cancers. Women who took the drug raloxifene were less likely to develop invasive, estrogen-receptor (ER) positive breast cancer compared with women who did not take the drug. Open Open Tab June 16, 2008 Provides Information Antibody To Breast Cancer-secreted Protein Blocks Metastasis Scientists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have made a key discovery about the mechanism of breast cancer metastasis, the process by which cancer spreads. Focusing on a gene dubbed "Dachshund," or DACH1, they are beginning to pinpoint new therapeutic targets to halt the spread of cancer. Open Open Tab July 8, 2008 Provides Information Antioxidant Supplements May Lessen Benefit Of Radiation And Chemotherapy Cancer patients should avoid the routine use of antioxidant supplements during radiation and chemotherapy because the supplements may reduce the anticancer benefits of therapy, researchers concluded in a commentary published online in the Journal of the National Cancer Institute. Open Open Tab May 28, 2008 Provides Information Arana and Greenovation in anti-cancer co-development deal Arana and Greenovation will combine their respective technologies to develop up to five potent anti-cancer antibodies. The combination of these technologies is expected to lead to enhanced potency next generation antibodies and more effective anti-cancer therapies. Open Open Tab June 2, 2008 Provides Information Arsenic-based Therapy Shown To Help Eradicate Leukemia-initiating Cells In both leukemia and solid tumors, there exists among the multitude of warrior cancer cells a small subgroup that work undercover, patiently lying in wait to launch their attacks. Open Open Tab May 12, 2008 Provides Information Asbestos-induced lung cancer patients do not appear to benefit from chemotherapy Adding chemotherapy to established methods of symptom management does not appear to enhance the quality of life or survival of patients suffering from an asbestos-induced form of lung cancer called malignant plural mesothelioma (MPM). Open Open Tab May 18, 2008 Provides Information Aspirin and other NSAIDs could lower the risk of breast cancer Taking aspirin on a daily basis may lower women's risk of a particular type of breast cancer, according to results published in BioMed Central's open access journal Breast Cancer Research. Open Open Tab April 30, 2008 Provides Information Awareness of the role of physical activity in colon cancer prevention Many experts now consider colon cancer a largely preventable disease, but a new study finds that primary care doctors might not always inform patients about one important step they can take to reduce their risk: becoming more physically active. Open Open Tab July 17, 2008 Provides Information B Bavarian Nordic enters trials with prostate cancer vaccine A Phase I/II safety and tolerability study in 18 male patients with non-metastatic as well as hormone-insensitive prostate cancer has begun enrolment in the US. Secondary objectives of the trial include examining the ability of the vaccine to induce prostate antigen-specific immune responses, as well as clinical anti-tumour activity. Preliminary data is expected during second half year 2009. Open Open Tab June 3, 2008 Provides Information Benign Breast Lumps: Another Wrinkle in Menopause Add another risk to hormone therapy after menopause: Benign breast lumps. One type of hormone therapy -- estrogen plus progestin -- already is well-known to increase the risk of breast cancer. But a major study of women able to use estrogen alone didn't find that link. Open Open Tab April 9, 2008 Provides Information Bicarbonate 'could detect cancer' The naturally-occurring chemical bicarbonate, used to make baking soda, could help detect cancer using sensitive scanning, research suggests. Open Open Tab May 28, 2008 Provides Information BioAlliance Pharma Suspends the Phase II/III Trial of Doxorubicin Transdrug in Primary Liver Cancer BioAlliance Pharma SA (Euronext Paris -BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, announced today the suspension of its Phase II trial of doxorubicin Transdrug® in primary liver cancer. Open Open Tab July 16, 2008 Provides Information Biochips can detect cancers before symptoms develop In their fight against cancer, doctors have just gained an impressive new weapon to add to their arsenal. Researchers at the U.S. Department of Energy's Argonne National Laboratory have developed a chip that can save lives by diagnosing certain cancers even before patients become symptomatic. Open Open Tab May 12, 2008 Provides Information Bioluminescence Imaging , a New Technique to Track Tumors The gene responsible for lighting up fireflies is being capitalized by UT Southwestern researchers to track the blood flow to tumor regions. Open Open Tab May 29, 2008 Provides Information Biomarker May Predict Response to Cancer Therapy A biomarker that may help doctors monitor the effectiveness of common treatments for kidney cancer and non-small cell lung cancer has been identified by researchers in the Netherlands. Open Open Tab April 13, 2008 Provides Information Biomarkers Of Early-stage Pancreatic Cancer In Mice And Man Identified A multicenter team of researchers has identified a panel of proteins linked to early development of pancreatic cancer in mice that applies also to early stages of the disease in humans -- a breakthrough that brings scientists a significant step closer to developing a blood test to detect the disease early, when cure rates are highest. Open Open Tab June 12, 2008 Provides Information Bionovo discovers new estrogen regulatory elements for breast cancer and osteoporosis drugs Bionovo Inc. today announced results on the role of estrogen regulatory elements important in developing drugs for breast cancer and osteoporosis. Open Open Tab June 16, 2008 Provides Information Blocking Key Energy Protein Kills Cancer Cells, First Evidence Provided Researchers in Taiwan report for the first time that blocking a key energy-supplying protein kills cancer cells. The finding, described as the first to test possible medical uses of so-called ATP-synthase inhibitors, may lead to new and more effective anti-cancer medications. Open Open Tab April 2, 2008 Provides Information Blocking Signaling Protein Prevents Prostate Cancer Spread, Scientists Find Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have shown that by blocking a signaling protein, they can prevent prostate cancer cells from metastatic dissemination. The work opens the door to future studies examining the protein as a target for therapies aimed at keeping prostate cancer at bay. Open Open Tab June 5, 2008 Provides Information Blocking The Effect Of Inflammation-causing Cells Lowered Prostate Cancer Cells Invasion Recent studies have suggested an association between chronic inflammation and cancers of the prostate, colon, stomach and liver. Now scientists at Northwestern University Feinberg School of Medicine report success in blocking an early step in metastasis of prostate cancer cells by interrupting the communication between the cancer cells and other cells that promote inflammation. Open Open Tab April 11, 2008 Provides Information Blood Pressure Drugs Halt Pancreatic Cancer Cell Growth, Researchers Find Researchers at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia are inching closer to understanding how common blood pressure medications might help prevent the spread of pancreatic cancer. They have found in the laboratory that one type of pressure-lowering drug called an angiotensin receptor blocker inhibits pancreatic cancer cell growth and causes cell death. Open Open Tab April 15, 2008 Provides Information Blood Test Can Help Improve Treatment Outcomes For Breast Cancer Patients With the goal of tailoring cancer treatment for each individual, researchers at Georgetown University Medical Center today presented a study suggesting a simple blood test can help doctors more reliably assess treatment efficacy for patients with metastatic breast cancer. Open Open Tab May 20, 2008 Provides Information Blue Light Used To Harden Tooth Fillings Stunts Tumor Growth A blue curing light used to harden dental fillings also may stunt tumor growth, Medical College of Georgia researchers say. Open Open Tab June 28, 2008 Provides Information BN ImmunoTherapeutics starts clinical trials with prostate cancer vaccine A Phase I/II safety and tolerability study in 18 male patients with non-metastatic as well as hormone-insensitive prostate cancer has begun enrolment in the US. Secondary objectives of the trial include examining the ability of the vaccine to induce prostate antigen-specific immune responses, as well as clinical anti-tumor activity. Preliminary data is expected during second half year 2009. Open Open Tab June 4, 2008 Provides Information Bone Drug Could Help Prevent The Spread Of Breast Cancer Maintaining bone density could be a key to decreasing the spread of cancer in women with locally advanced breast cancer, according to research at Washington University School of Medicine in St. Louis. Open Open Tab May 19, 2008 Provides Information Bone Marrow Transplants: Cancer Drug Shows Promise Against Graft Vs. Host Disease A new University of Michigan study in mice suggests that a drug recently approved to fight cancer tumors is also able to reduce the effects of graft-versus-host disease, a common and sometimes fatal complication for people who have had bone marrow transplants. Open Open Tab July 16, 2008 Provides Information Boost for cancer research in Leicestershire A new approach to pain relief, investigation of a gene that triggers colorectal cancer and the prevention, early diagnosis and treatment of ovarian cancer are three research projects at the University of Leicester, which are to benefit from funding from the Leicestershire and Rutland charity Hope Against Cancer. Open Open Tab May 21, 2008 Provides Information Boy's Body Attacked His Brain Mistaking It for Cancer Fifteen-month-old Finn McConnell was diagnosed with a rare chest tumor late last year that fooled his body into believing his own brain was cancerous. Open Open Tab April 10, 2008 Provides Information Brain Cancer Vaccine's Immune Response Key to Outcomes An in-trial dendritic cell vaccine that fights malignant brain tumors called glioblastoma multiforme (GBM) may help boost a patient's immunity response and improve the outcome, a new report says. Open Open Tab July 15, 2008 Provides Information Brain damage link to cancer drug A drug widely used to treat cancer may cause brain damage, with the effects lasting for years after the end of treatment, research suggests. Open Open Tab April 22, 2008 Provides Information Breast cancer gene a culprit in prostate cancer Australian researchers have discovered that a mutated version of the BRCA-2 gene known to lead to breast and ovarian cancer, is also a culprit in prostate cancer in men. Open Open Tab May 19, 2008 Provides Information Breast cancer researchers call for ethnicity to be taken into account when developing treatments Breast cancer research needs to investigate how a person's ethnicity influences their response to treatment and its outcome, according to a new Comment piece in today's Lancet by researchers from Imperial College London. Open Open Tab July 17, 2008 Provides Information Breast Cancer Risk Amplified By Additional Genes In Combo With BRCA Mutation Researchers at the University of Pennsylvania School of Medicine join an international consortium of research groups that looked at more than 10,000 women carrying a BRCA1 or BRCA2 mutation for breast-cancer risk. Open Open Tab April 18, 2008 Provides Information Breast Cancer Subtypes Originate From Different Biological Pathways here is a biological distinction between breast cancers that depend on hormones and those that do not, according to new research. Open Open Tab April 28, 2008 Provides Information Breast Cancer: How Tumor Cells Break Free And Form Metastases When tumor cells acquire the capacity to move around and invade other tissues, there is a risk of metastases and cancer treatment becomes more difficult. At the Institut Curie, CNRS Director of Research Philippe Chavrier and his group have just discovered how breast cancer cells break the bonds that tether them to the tumor. Open Open Tab July 5, 2008 Provides Information Breast Cancers : What If Their Invasive Power Were 'Latent' From The Beginning Of Their Development? Why are some cancers more aggressive than others? This was the question explored by a number of doctors and other research scientists at the Institut Curie when they studied the biological profile of a form of breast cancer. Open Open Tab April 15, 2008 Provides Information British volunteers needed to help bring cure for cancer closer Researchers, who are in the process of developing a blood test that may diagnose breast cancer up to four years earlier than a mammogram, need the help of thousands of people living in the East Midlands. Open Open Tab April 21, 2008 Provides Information By 2024 one in seven women will be diagnosed with breast cancer Experts in Britain are predicting that by 2024 one in seven women will be diagnosed with breast cancer if there is not an improvement in public health trends. Open Open Tab June 2, 2008 Provides Information C Calorie Restricted Diet Prevents Pancreatic Inflammation And Cancer Prevention of weight gain with a restricted calorie diet sharply reduced the development of pancreatic lesions that lead to cancer in preclinical research reported April 15 by researchers from The University of Texas at Austin and The University of Texas M. D. Anderson Cancer Center at the American Association for Cancer Research annual meeting. Open Open Tab April 17, 2008 Provides Information Calorie Restriction Limits -- And Obesity Fuels -- Development Of Epithelial Cancers A restricted-calorie diet inhibited the development of precancerous growths in a two-step model of skin cancer, reducing the activation of two signaling pathways known to contribute to cancer growth and development, researchers at The University of Texas M. D. Anderson Cancer Center report April 14 at the American Association for Cancer Research annual meeting. Open Open Tab April 15, 2008 Provides Information Can Gold help cure cancer? Can gold be used in curing cancer? A report that appeared in The Washington Post says gold particles can help fight cancer. Open Open Tab April 29, 2008 Provides Information Can These 'Magic Mushrooms' Fight Cancer? A mushroom widely used in oriental medicine may help fight breast cancer by slowing the growth of tumors and starving them of blood, a study has shown. Open Open Tab April 17, 2008 Provides Information Cancer cases up but survival more than doubles in breast and bowel cancer The number of people surviving some of the most common types of cancer for at least five years has doubled since the National Health Service was founded 60 years ago. Open Open Tab July 3, 2008 Provides Information Cancer cells revert to normal at specific signal threshold But scientists at the Stanford University School of Medicine report that lowering levels of one cancer signal under a specific threshold reverses this process in mice, returning tumor cells to their normal, healthy state. The finding could help target cancer chemotherapy to tumors while minimizing side effects for the body's healthy cells. Open Open Tab July 1, 2008 Provides Information Cancer Cells Spread By Releasing 'Bubbles', According To New Study A new fundamental mechanism of how tumour cells communicate has just been discovered by the team of Dr. Janusz Rak at the Research Institute of the McGill University Health Centre (MUHC) in collaboration with Dr Guha from the University of Toronto. The cancer cells are able to communicate with their more healthy counter-parts by releasing vesicles. Open Open Tab April 22, 2008 Provides Information Cancer Cure In Mice To Be Tested In Humans Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice. Open Open Tab June 28, 2008 Provides Information Cancer cure in mice to be tested in humans Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice. Open Open Tab June 30, 2008 Provides Information Cancer Detection and Therapy to be Enhanced With Fluorine Based Nanoparticles Perfluorocarbons, a class of inert, oily polymers, have a proven track record in a variety of clinical uses, including in contrast-enhanced ultrasound imaging and in eye surgery to correct a detached retina. Researchers at the Siteman Center of Cancer Nanotechnology Excellence (Siteman CCNE), led by longtime Washington University School of Medicine collaborators Samuel Wickline, M.D., and Gregory Lanza, M.D., are well on the way to developing a new use for perfluorocarbons: as the building blocks for nanoparticles capable of delivering a wide range of imaging agents and drugs to tumors. Three recently published papers highlight their progress. Open Open Tab April 21, 2008 Provides Information Cancer doctors dodge the death talk One look at Eileen Mulligan lying soberly on the exam table and Dr. John Marshall knew the time for the Big Talk had arrived. Open Open Tab June 16, 2008 Provides Information Cancer Drug May Help Patients With Heart-lung Disease A drug developed to fight cancer is showing early promise as a treatment for pulmonary hypertension, researchers from the University of Chicago Medical Center report May 19 at the American Thoracic Society International Conference in Toronto, Canada. Open Open Tab May 21, 2008 Provides Information Cancer gene test 'for all women' A simple test for gene faults which increase the risk of breast cancer is getting nearer, UK scientists suggest. Open Open Tab June 26, 2008 Provides Information Cancer Immunotherapy Reduces Risk Of Relapse After Surgery New, long-term results from a clinical trial presented today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery -- to the same extent as chemotherapy but without the side-effects of chemotherapy. Open Open Tab April 26, 2008 Provides Information Cancer Killing Machine Developed by Nanotechnology Researchers Researchers from the Nano Machine Center at the California NanoSystems Institute at UCLA have developed a novel type of nanomachine that can capture and store anticancer drugs inside tiny pores and release them into cancer cells in response to light. Open Open Tab April 2, 2008 Provides Information Cancer Metastasis: Cellular Decisions Predicted With Computer Program Scientists of the Division of Theoretical Bioinformatics at the German Cancer Research Center in Heidelberg have simulated on the computer how cells decide whether or not to migrate. Using their results, the researchers were able to predict the molecular targets within a cell that have to be hit so that its behavior changes in a particular direction. This method may help to develop new treatments against cancer metastasis. Open Open Tab July 16, 2008 Provides Information Cancer Patients' Quality Of Life Directly Relates To Their Survival Patients who feel better live longer, say Mayo Clinic researchers, working with the North Central Cancer Treatment Group (NCCTG), in study results released May 15 as part of the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO). Open Open Tab May 16, 2008 Provides Information Cancer Researchers Call For Ethnicity To Be Taken Into Account Breast cancer research needs to investigate how a person's ethnicity influences their response to treatment and its outcome, according to a new Comment piece published in The Lancet July18 by researchers from Imperial College London. Open Open Tab July 19, 2008 Provides Information Cancer Research UK and AstraZeneca announce innovative deal for promising anti-cancer compound Cancer Research UK and Cancer Research Technology (CRT) - the charity's development and commercialisation arm - today announced an innovative new arrangement to progress into clinical development a potential anti-cancer compound from AstraZeneca. Open Open Tab May 19, 2008 Provides Information Cancer Research: A Common Denominator Of Inflammations And Fatty Liver Found Many cancer patients lose a lot of weight during their disease: Fat and muscle mass are reduced, free fatty acids accumulate in the liver, and this eventually leads to fatty liver in affected patients. What is called tumor cachexia appears to be caused by signals emitted by the tumor itself. Open Open Tab May 28, 2008 Provides Information Cancer Stem Cells May Be At The Root Of Brain Tumors Stem cells -- popularly known as a source of biological rejuvenation -- may play harmful roles in the body, specifically in the growth and spread of cancer. Amongst the wildly dividing cells of a tumor, scientists have located cancer stem cells. Open Open Tab May 19, 2008 Provides Information Cancer Survival Rates Vary by Country Study Shows U.S., Japan, and France Have Highest Cancer Survival Rates Open Open Tab July 16, 2008 Provides Information Cancer Therapy Without Side Effects Nearing Trials A promising new cancer treatment that may one day replace radiation and chemotherapy is edging closer to human trials. Open Open Tab April 13, 2008 Provides Information Cancer treatment from a common avian virus under study Researchers on the Blacksburg and College Park, Maryland campuses of the Virginia-Maryland Regional College of Veterinary Medicine have been awarded a major new grant from the National Institutes of Health (NIH) to support innovative work that seeks to develop a treatment for cancer from a common avian virus. Open Open Tab April 7, 2008 Provides Information Cancer Treatment: Selecting Patients Based On Genotype May Increase Efficacy Of Tamoxifen Breast cancer patients who carry the wild-type gene required for tamoxifen metabolism may have comparable risk of recurrence when taking tamoxifen or an aromatase inhibitor, according to modeling data. Open Open Tab April 30, 2008 Provides Information Cancer warning on diabetic ulcer gel The U.S. watchdog the Food and Drug Administration (FDA) says a warning will be added to the label of a topical gel used to treat leg and foot ulcers which refuse to heal in diabetic patients. Open Open Tab June 9, 2008 Provides Information Cancer-killing Viruses Influence Tumor Blood-vessel Growth Viruses genetically designed to kill cancer cells offer a promising strategy for treating incurable brain tumors such as glioblastoma, but the body's natural defenses often eliminate the viruses before they can eliminate the tumor. Open Open Tab June 11, 2008 Provides Information Carbon-coated Nanomagnets Could Be A New Form Of Cancer Treatment Carbon-coated nanomagnets may offer a new form of cancer treatment. Research presented at the 103rd Annual Scientific Meeting of the American Urological Association (AUA) suggests that nanoparticles consisting of metallic iron with a protective carbon coat could serve as a safe and effective hyperthermia agent. Open Open Tab May 17, 2008 Provides Information Case Points to Link Between Crohn's Treatment, Cancer An unusual case involving a sudden remission of lung cancer highlights the carcinogenic potential of certain drugs used to treat Crohn's disease, experts say. Open Open Tab July 16, 2008 Provides Information Cases of Deadly Skin Cancer in Young Women Increase by 50 Percent Cases of the deadliest form of skin cancer are on the rise among young women, but not young men, according to a study published Thursday in the Journal of Investigative Dermatology. Open Open Tab July 11, 2008 Provides Information Celebrex Plus Lipitor Could Fight Prostate Cancer Two widely used drugs -- one lowers cholesterol and one is an anti-inflammatory -- may be useful in controlling prostate cancer. Open Open Tab April 14, 2008 Provides Information Certain Anticancer Agents Could Be Harmful To Patients With Heart Disease A set of promising new anticancer agents could have unforeseen risks in individuals with heart disease, suggests research at Washington University School of Medicine in St. Louis. The anticancer drugs -- which go by the strange name of hedgehog antagonists -- interfere with a biochemical process that promotes growth in some cancer cells. Open Open Tab June 25, 2008 Provides Information Cervical cancer shot not cleared for ages 27-45 FDA found 'issues' in review of Gardasil for older women, approval delayed Open Open Tab June 25, 2008 Provides Information Change Lifestyle, Change Genes 3 Months on Ornish Diet Changes 500 Genes, Many With Anticancer Effects. Open Open Tab June 16, 2008 Provides Information Chemical Compound Prevents Cancer In Lab While researching new ways to stop the progression of cancer, researchers at the University of Oklahoma Health Sciences Center, have discovered a compound that has shown to prevent cancer in the laboratory. Open Open Tab May 14, 2008 Provides Information Chemists create cancer-detecting nanoparticles Magnetic resonance imaging (MRI) can be a doctor's best friend for detecting a tumor in the body without resorting to surgery. MRI scans use pulses of magnetic waves and gauge the return signals to identify different types of tissue in the body, distinguishing bone from muscle, fluids from solids, and so on. Open Open Tab June 13, 2008 Provides Information Chemo pill shows promise for advanced lymphoma A new chemotherapy pill for people with stubborn lymphomas is showing promise in early clinical studies, according to scientists at the University of Rochester's James P. Wilmot Cancer Center. Doctors reported that the drug is halting disease in nearly half of the patients with two forms of lymphoma participating in early clinical trials in Rochester and across the country. Open Open Tab July 15, 2008 Provides Information Chemotherapy Causes Delayed Severe Neural Damage Cancer treatment with chemotherapeutic agents is often associated with delayed adverse neurological consequences - an occurrence often referred to as "chemobrain" - that may compromise the quality of life of a proportion of cancer survivors. Open Open Tab April 22, 2008 Provides Information Chemotherapy Diminishes Fertility In Breast Cancer Patients Pre-menopausal breast cancer survivors who were treated with chemotherapy following surgery were more likely to have diminished ovarian reserve -- the capacity of the ovaries to provide eggs capable of being fertilized - compared to women who have never had breast cancer. Open Open Tab June 2, 2008 Provides Information Chemotherapy May Not Affect Memory In Breast Cancer Patients Women receiving chemotherapy for breast cancer frequently report problems with memory and concentration, but two new studies suggest that chemotherapy is not the cause of these problems, and the stress of the diagnosis may be. Open Open Tab April 17, 2008 Provides Information Chemotherapy Might Help Cancer Vaccines Work Chemotherapy given in conjunction with cancer vaccines may boost the immune system's response, potentially improving the effectiveness of this promising type of cancer therapy, according to a study by researchers in the Duke Comprehensive Cancer Center. Open Open Tab May 18, 2008 Provides Information Chemotherapy-induced Anemia Increases Risk Of Local Breast Cancer Recurrence Patients with breast cancer who developed anemia during chemotherapy had nearly three times the risk of local recurrence as those who did not, according to a study published in the April 1 issue of Clinical Cancer Research. Open Open Tab April 3, 2008 Provides Information Chemotherapy's Damage To The Brain Detailed A commonly used chemotherapy drug causes healthy brain cells to die off long after treatment has ended and may be one of the underlying biological causes of the cognitive side effects -- or "chemo brain" -- that many cancer patients experience. That is the conclusion of a study published today in the Journal of Biology. Open Open Tab April 22, 2008 Provides Information Childhood Cancer Rates Highest in Northeast Surprising research suggests that childhood cancer is most common in the Northeast, results that even caught experts off guard. But some specialists say it could just reflect differences in reporting. Open Open Tab June 2, 2008 Provides Information Children's Brain Tumor Foundation's tissue bank consortium may solve dire problem in pediatric cancer research In a major effort to speed treatment and cures for pediatric brain tumors and cancer, the Children's Brain Tumor Foundation (CBTF) today launched the initial phase of a tissue bank consortium designed to jump-start meaningful analyses that could lead to treatment and cures for these types of cancer, where survival rates are unacceptably low and neurocognitive and other damage is posed by today's treatment options. Open Open Tab July 1, 2008 Provides Information Chip-based device measures drug resistance in tumor cells Multiple drug resistance is a major cause of anticancer therapy failure. Most drug-resistance cancer cells develop this unfortunate characteristic due to a drug-pumping protein known as P-glycoprotein. Open Open Tab May 20, 2008 Provides Information Chip-based device measures drug resistance in tumor cells Multiple drug resistance is a major cause of anticancer therapy failure. Most drug-resistance cancer cells develop this unfortunate characteristic due to a drug-pumping protein known as P-glycoprotein. Open Open Tab May 21, 2008 Provides Information Circulating Tumor Cells Can Reveal Genetic Signature Of Dangerous Lung Cancers Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy. Open Open Tab July 4, 2008 Provides Information Cisplatin found to be less effective than standard treatment for patients with anal cancer When administered before chemoradiation, the common anti-cancer drug cisplatin neither improved disease-free survival nor reduced the number of colostomies needed when compared to the standard treatment for patients with anal canal cancer. Open Open Tab April 22, 2008 Provides Information Clone cell cancer 'cure' hailed Scientists claim they have cured advanced skin cancer for the first time using the patient's own cells cloned outside the body. Open Open Tab June 18, 2008 Provides Information Closing In On New Melanoma Gene It has long been known that prolonged exposure to the suns harmful UV rays can lead to Melanoma, the deadliest form of skin cancer. An unanswered question, however, is why some people are more likely to develop melanoma than others. Open Open Tab May 20, 2008 Provides Information Colon Cancer Screening Sooner? Prevalence Of Pre-cancerous Masses In Colon Same In Patients In Their 40s And 50s Currently, standard protocol recommends screening patients age 50 and over for colon cancer based on the increasing incidence of colon cancer at that age. Open Open Tab May 30, 2008 Provides Information Colon Cancer Vaccine on the Horizon Researchers hope that a protein found in the intestines could lead to the discovery of a vaccine for colon cancer, Reuters reported Tuesday. Open Open Tab June 25, 2008 Provides Information Colorectal cancer screening rates still too low Although colorectal cancer screening tests are proven to reduce colorectal cancer mortality, only about half of U.S. men and women 50 and older receive the recommended tests. Open Open Tab July 14, 2008 Provides Information Combination Of Two Novel Anti-cancer Agents May Help Fight CML Resistant To Current Therapy Virginia Commonwealth University Massey Cancer Center researchers have identified that a combination of novel anti-cancer compounds is able to kill chronic myelogenous leukemia cells previously resistant to conventional forms of therapy. Open Open Tab June 1, 2008 Provides Information Combining Liver Cancer Treatments Doubles Survival Rates By combining the use of stents and photodynamic therapy, also called SpyGlass, physicians at the University of Virginia have been able to significantly increase survival rates for patients suffering from advanced cholangiocarcinoma, cancer of the liver bile duct. Open Open Tab April 19, 2008 Provides Information Combining Radiation And Surgery Significantly Improves Survival For Head And Neck Cancer Patients Adding radiation therapy to surgery significantly improves overall survival in patients diagnosed with node-positive head and neck cancer when compared to treating with surgery alone, according to a study in the June issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology. Open Open Tab June 14, 2008 Provides Information Complaints cause cervical cancer vaccine scrutiny A vaccine designed to prevent cervical cancer is coming under fresh scrutiny amid thousands of complaints linking it to a range of health problems. Open Open Tab July 7, 2008 Watch Video Computer Predicts Anti-cancer Molecules A new computer-based method of analyzing cellular activity has correctly predicted the anti-tumour activity of several molecules. New research published in Molecular Cancer describes 'CoMet' -- a tool that studies the integrated machinery of the cell and predicts those components that will have an effect on cancer. Open Open Tab June 19, 2008 Provides Information Cord blood cancer therapy boost Immune cells grown from umbilical cord blood may one day be used to improve leukaemia treatment, researchers say. Open Open Tab May 16, 2008 Provides Information Could Hair be Used to Detect Breast Cancer? The Australian company Fermiscan is developing a test that can potentially identify a patient with breast cancer using just 20 or so strands of hair. Open Open Tab July 1, 2008 Provides Information Crucial Factors In Lymphoma Development And Survival Discovered Researchers at National Jewish Medical and Research Center have discovered an important factor in the development of B-cell lymphomas, one of the fastest growing forms of cancer. The B-cell receptor on the surface of B cells can cooperate with the MYC oncogene to accelerate the development of lymphomas. Open Open Tab June 25, 2008 Provides Information D Data Re-analysis Shows Drug Finasteride May Reduce Risk For Most Prostate Cancers A re-analysis of data from the landmark Prostate Cancer Prevention Trial (PCPT) finds that finasteride reduces the risk for prostate cancer without boosting the odds of aggressive tumors. Open Open Tab May 24, 2008 Provides Information Death, Division Or Cancer? Newly Discovered Checkpoint Process Holds The Line In Cell Division Each day, a staggering number of cells perform a feat that still amazes researchers with its complexity: they divide to produce perfect replicas of each other. The process is called mitosis, and an inability to control it is one of the hallmarks of cancer. Open Open Tab July 4, 2008 Provides Information Dehydrated Tomatoes Show Promise For Preventing Prostate Cancer New research suggests that the form of tomato product one eats could be the key to unlocking its prostate cancer-fighting potential, according to a report in the June 1 issue of Cancer Research, a journal of the American Association for Cancer Research. Open Open Tab June 2, 2008 Provides Information Dendrimers improve imaging with magnetic nanoparticles Dendrimers are spherical polymer nanoparticles that have shown promise as targeted anticancer drug delivery vehicles. Iron oxide nanoparticles have already demonstrated the ability to image tumors and metastatic lesions. Now, researchers at the University of Michigan have combined the two, producing a layered nanoscale construct that targets and images tumors in animal models of human cancer. Open Open Tab May 21, 2008 Provides Information Designer diet for prostate cancer Eating one or more portions of broccoli every week can reduce the risk of prostate cancer, and the risk of localised cancer becoming more aggressive. Open Open Tab July 1, 2008 Provides Information Detecting and Analyzing Genetic Signature of Tumor Cells Using Laboratory-on-a-Chip Device The results from this analysis allowed the researchers to identify those patients most likely to respond to a specific targeted treatment. This chip-based analysis also allowed the researchers to monitor genetic changes that occur during therapy. Open Open Tab July 9, 2008 Provides Information Detecting Early Forms Of Cancer By Analyzing Structure of Specific Sugar Molecules In order to provide the most effective treatments for cancer patients, it is essential to develop methods of sensitive and specific early detection of the disease. A team of scientists from the NIBRT Dublin-Oxford Glycobiology Laboratory at UCD has developed a system which aims to pinpoint potential "biomarkers" of early forms of the disease. They do this by looking at the structures of specific sugar molecules which are attached either to proteins made by cancerous cells or to proteins involved in the host response. Open Open Tab July 12, 2008 Provides Information Developing Cancer Treatments Directed At Critical Developmental Pathway Researchers from the University of Pennsylvania School of Medicine and colleagues discovered that the Notch signaling pathway, which determines the development of many cell types, and is also implicated in some cancers, is not universally essential for the maintenance of stem cells. Open Open Tab April 14, 2008 Provides Information Diabetes Doubles Liver Cancer Risk For Patients With Advanced Hepatitis C Patients who have chronic hepatitis C with advanced fibrosis have twice the risk of developing liver cancer if they also have diabetes. Open Open Tab June 2, 2008 Provides Information Diagnosed With Breast Cancer at 21: A Survivor's Story Last summer, at the age of 21, Colleen Cappon was diagnosed with breast cancer. Open Open Tab April 15, 2008 Provides Information Different Type Of Colon Cancer Vaccine Reduces Disease Spread Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease. Open Open Tab June 26, 2008 Provides Information Digestive Process Affects Anti-cancer Activity Of Tea In Gastrointestinal Cells Increased consumption of teas rich in catechins is associated with reduced risk of stomach, colon and other gastrointestinal cancers. However, the effects of digestion on the anticancer activity of tea catechins have largely been ignored. Open Open Tab April 10, 2008 Provides Information Discovery of 250 new genes potentially involved in leukemia The research was performed in close collaboration between the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (Amsterdam, The Netherlands) and the Wellcome Trust Institute (Cambridge, UK) and will be published in the Friday May 16th issue of the scientific journal Cell. Open Open Tab May 15, 2008 Provides Information Discovery of mechanism that prevents cells from transforming into cancer cells MRC scientists have discovered a mechanism that prevents cells from transforming into cancer cells. As cells age they enter a state called senescence, a kind of suspended animation that allows a cell to keep functioning but prevents it from changing. This state can also be triggered by what's called an 'insult' to the cell, for example a signal from a cancer-initiating gene. Open Open Tab June 15, 2008 Provides Information Discovery of protein that helps predict prostate cancer survival An Oregon Health & Science University Cancer Institute researcher has identified a protein that is a strong indicator of survival for men with advanced prostate cancer. Open Open Tab April 22, 2008 Provides Information Discovery Offers New Avenues To Understanding An Aggressive Form Of Leukemia Researchers at St. Jude Children¡¦s Research Hospital have discovered evidence that a series of genetic mutations work together to initiate most cases of an aggressive and often-fatal form of acute lymphoblastic leukemia (ALL). Open Open Tab April 15, 2008 Provides Information Discovery provides hope for patients with pancreatic cancer This week researchers in the Oregon Health & Science University (OHSU) Oregon Stem Cell Center and the OHSU Digestive Health Center are shining a new ray of hope on patients with pancreatic cancer. They've developed new reagents, or antibodies, that can recognize this often lethal disease. This important discovery may one day lead to earlier detection and treatment. Open Open Tab May 22, 2008 Provides Information DNA Building Block Creation Seen In Living Cells: Could Be Key To New Cancer Treatments Also called purines, the two building blocks are essential for cell replication. The findings, which will be published in the 4 April 2008 issue of the journal Science, could lead to new cancer treatments that prevent cancer cells from replicating by interfering with their abilities to make purines. Open Open Tab April 4, 2008 Provides Information DNA modification seen in colorectal tumors helps predict outcomes, John Wayne Cancer Institute researchers find An international study led by researchers at the John Wayne Cancer Institute at Saint John's Health Center has found that modifications to DNA found on multiple chromosomes in tumors can help to predict outcomes in patients with early-stage rectal cancer. Open Open Tab May 21, 2008 Provides Information Dogs successfully detect ovarian cancer through scent Ground-breaking research in the June issue of Integrative Cancer Therapies published by SAGE explored whether ovarian cancer has a scent different from other cancers and whether working dogs could be taught to distinguish it in its different stages. Open Open Tab June 26, 2008 Provides Information Double binding sites on tumor target may provide future combination therapy Researchers from the University of Pennsylvania School of Medicine and colleagues at Merck Serono Research in Germany have found that two drugs bind to receptor sites on some tumors in different places at the same time, suggesting the possibility of a new combination therapy for certain types of cancer. Open Open Tab April 9, 2008 Provides Information Drug Compound Leads To Death Of Ovarian Cancer Cells Resistant To Chemotherapy In a discovery that may be useful for maintaining remission in chemo-resistant ovarian cancer, Yale scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the death of ovarian cancer cells by halting the activation of a protein pathway called mTOR. Open Open Tab April 21, 2008 Provides Information Drug Fends Off Kidney Cancer Progression New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments. Open Open Tab May 20, 2008 Provides Information Drug Found To Stimulate Immune System In Patients With Prostate Cancer In a multi-site study, Oregon Health & Science University Cancer Institute researchers have found that a drug called Ipilimumab, also known as MDX-010, works to stimulate the body's own immune system to fight prostate cancer. Open Open Tab June 3, 2008 Provides Information Drug Helps Lung Cancer Patients Live Longer Adding the novel cancer drug Erbitux to standard chemotherapy helped advanced lung cancer patients live just a month longer than chemo alone, a study found. Open Open Tab June 1, 2008 Provides Information Drug Therapy To Bolster Immune System Cells Found Effective Toward Childhood Cancer Researchers from The University of Texas M. D. Anderson Cancer Center have found a possible approach to therapy that may make cancer cells more sensitive to attack by immune system cells while making the immune system cells more powerful. Open Open Tab May 19, 2008 Provides Information Dual Functions Of Gene Revealed, For Better And For Worse Researchers at WEHI have pinpointed the function of a potent cancer gene. Open Open Tab May 28, 2008 Provides Information E Early Clinical Trial Results Back New Drug For Melanoma Rutgers Professor Suzie Chen has found that riluzole, a U.S. Food and Drug Administration (FDA) approved drug used to treat Lou Gehrig's disease (ALS), slows the growth of melanoma, the most aggressive form of malignant skin cancer. Open Open Tab April 18, 2008 Provides Information Early diagnosis vital in oesophageal cancer detection People with oesophageal cancer are often enduring serious symptoms for over a year before seeking help according to a report launched by the Northern Ireland Cancer Registry at Queen's. Open Open Tab April 22, 2008 Provides Information Eating Broccoli May Keep Prostate Cancer Away Eating one or more portions of broccoli every week can reduce the risk of prostate cancer, and the risk of localised cancer becoming more aggressive. Open Open Tab July 2, 2008 Provides Information Eating Soy Foods In Puberty Protects Against Breast Cancer, Evidence Now Suggests Evidence is growing from animal and human studies that genistein, a potent chemical found in soy, protects against development of breast cancer - but only if consumed during puberty, says a Georgetown University Medical Center researcher in the British Journal of Cancer. Open Open Tab April 9, 2008 Provides Information Effective Colon Cancer Prevention Treatment Discovered Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects. Open Open Tab April 16, 2008 Provides Information Emotional writing may help ease cancer pain Patients who wrote about their feelings had less discomfort. Open Open Tab July 18, 2008 Provides Information Ending Moderate Drinking Tied To Depression Scientific evidence has long suggested that moderate drinking offers some protection against heart disease, certain types of stroke and some forms of cancer. Open Open Tab July 9, 2008 Provides Information Enzyme May Hold Key To Improved Targeting Of Cancer-fighting Drugs Building on their earlier research into neocarzinostatin, a team of researchers from Boston College and the University of Wisconsin, Madison discovered that one of the enzymes contained in the bacteria used to produce the drug may hold promise in creating newer, more stable compounds from the structurally complex class of antibiotic known as chromoproteins. Open Open Tab June 1, 2008 Provides Information Estrogen Helps Drive Distinct, Aggressive Form Of Prostate Cancer Using a breakthrough technology, researchers led by a Weill Cornell Medical College scientist have pinpointed the hormone estrogen as a key player in about half of all prostate cancers. Open Open Tab May 29, 2008 Provides Information Exercise cuts cancer deaths in men A team of scientists from the Karolinska Institute in Sweden looked at the effect of physical activity and cancer risk in 40,708 men aged between 45 and 79. The seven year study found that men who walked or cycled for at least 30 minutes a day had a 34 per cent lower risk of dying from cancer than the men who did less exercise or nothing at all. Open Open Tab May 27, 2008 Provides Information Experimental Anti-cancer Synthetic Molecule Targets Tumor Cell Growth And Angiogenesis A recent study conducted by three French CNRS (Centre National de la Recherche Scientifique) laboratories describes a new candidate anti-cancer drug, named HB-19. In contrast to conventional anti-cancer drugs, HB-19 has a dual mechanism of action by its capacity to target independently both tumor cell growth, as well as tumor angiogenesis (formation of new blood vessels which bring necessary nutrients and oxygen to the tumor mass). Open Open Tab June 20, 2008 Provides Information Experimental drug blocks prostate cancer in animal study An experimental drug has blocked the progression of prostate cancer in an animal model with an aggressive form of the disease, new research shows. Open Open Tab May 22, 2008 Provides Information Expert says Wembley Stadium could be filled with 'preventable' cancer cases A British cancer expert has come up with a novel way of illustrating how a healthy lifestyle can beat cancer. Open Open Tab May 15, 2008 Provides Information F Factors in Cancer Death Rates Stay Stagnant The factors behind cancer death rates seem to have stagnated, a new report shows, as the smoking prevention and mammography screening efforts that fueled recent declines in cancer deaths appear to have leveled off. Open Open Tab April 22, 2008 Provides Information Familial Breast Cancer Risk Continues Throughout a Woman's Life Women who have a sister diagnosed with breast cancer are at an increased risk of developing the disease throughout their lives. The increased risk is most pronounced in younger women, regardless of the age at which the first sister was diagnosed. Open Open Tab May 15, 2008 Provides Information Family History Of Colorectal Cancer Linked With Reduced Risk Of Cancer Recurrence Among patients with advanced colon cancer receiving treatment that includes chemotherapy, a family history of colorectal cancer is associated with a significant reduction in cancer recurrence and death, with the risk reduced further by having an increasing number of affected first-degree relatives, according to a new study. Open Open Tab June 6, 2008 Provides Information Fasting could offer protection from chemotherapy effects A new study is suggesting that short-term fasting could help protect cancer patients against the effects of chemotherapy. Open Open Tab April 1, 2008 Provides Information Fat stomach raises pancreatic cancer risk Obese women 70 percent more likely to develop deadly disease, study finds Open Open Tab July 16, 2008 Provides Information Faulty DNA Repair Could Be A Risk Factor For Lung Cancer In Nonsmokers People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at higher risk of developing lung cancer than those with effective genomic repair capability. Open Open Tab June 27, 2008 Provides Information FDA Adds Cancer Warning to Foot Cream The Food and Drug Administration warned patients Friday that using large amounts of a Johnson & Johnson foot ulcer medication could heighten their risk of dying from cancer. Open Open Tab June 9, 2008 Provides Information FDA Approval For Trials of Nanotechnology Based Cancer Drug Delivery System Calando Pharmaceuticals, a majority owned subsidiary of Arrowhead Research Corporation, announced today that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug application (IND) for lead anti-cancer compound, CALAA-01. Open Open Tab April 22, 2008 Provides Information FDA Checking for Cancer-TNF Drug Link Cancers Reported in Some Kids Taking Remicade, Enbrel, Humira, and Cimzia Open Open Tab June 4, 2008 Provides Information FDA Grants Approval to First Digital Mammograph With Computer Aided Detection iCAD Inc. has announced that the FDA approved the integration of its SecondLook Digital tumor detection system with Fuji's FCRm tomograph. Open Open Tab April 4, 2008 Provides Information FDA Probes Arthritis, Crohn's Drugs for Cancer Link Federal regulators are investigating whether a group of best-selling arthritis drugs made by Abbott Laboratories, Schering-Plough Corp. and other companies heighten the risk of cancer in youngsters.